chr15-49335465-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152647.3(FAM227B):āc.1303A>Cā(p.Lys435Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_152647.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAM227B | NM_152647.3 | c.1303A>C | p.Lys435Gln | missense_variant | 14/16 | ENST00000299338.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAM227B | ENST00000299338.11 | c.1303A>C | p.Lys435Gln | missense_variant | 14/16 | 2 | NM_152647.3 | P1 | |
GALK2 | ENST00000558399.5 | c.426+15660T>G | intron_variant | 5 | |||||
GALK2 | ENST00000559580.5 | c.448+7335T>G | intron_variant | 5 | |||||
FAM227B | ENST00000559573.3 | n.421-3616A>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152222Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461342Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 727024
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152222Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74366
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.1303A>C (p.K435Q) alteration is located in exon 14 (coding exon 13) of the FAM227B gene. This alteration results from a A to C substitution at nucleotide position 1303, causing the lysine (K) at amino acid position 435 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at